Efficacy, safety, and immunogenicity of an Escherichia coli-produced bivalent human papillomavirus vaccine: An interim analysis of a randomized clinical trial.
Hits:
Journal:J Natl Cancer Inst
Indexed by:Unit Twenty Basic Research
Issue:2019 May 11. pii: djz074. doi: 10.1093/jnci/djz074